UBC Faculty Research and Publications

CeMCOR Protocol : Peri-P-236267-01 Prior, Jerilynn C., 1943-; Cameron, Andrea; Fung, Michelle; Hitchcock, Christine L.; Kalyan, Shirin; Sirrs, Sandra; Janssen, Patricia A.; Singer, Joel; Brief, Elana; Ferris, Caroline

Description

This is a randomized, double-masked, placebo-controlled trial of oral micronized progesterone (300 mg at bedtime daily) for hot flushes and night sweats (collectively vasomotor symptoms, VMS) in women stratified to be in Early or Late Perimenopause. We have recently completed a similar trial showing that oral micronized progesterone provides effective therapy for healthy postmenopausal women with VMS. Currently there is no effective, evidence based treatment for perimenopausal VMS. [The approved amendments to the posted 2014 protocol and Ethics Chair's letter of explanation were added on December 5, 2018.]

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International